First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune®.

This prospective study suggests that Uromune is safe and effective at preventing UTIs in women. Further research is required in larger groups of patients for longer treatment times. An international double-blind randomized control trial comparing Uromune with placebo is currently underway.